Drawing for ESSENTIAL CRO

USPTO serial 78387269

ESSENTIAL CRO

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
RIRIE, VERNA BETH
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ESSENTIAL CRO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Sandra B. Weiss

SANDRA B WEISS JONES DAY77 W WACKER ST STE 3500CHICAGO, IL 60601-1692UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Providing general business administration and management services on behalf of entities providing public or private clinical trials, medical studies or market research studies of pharmaceutical, pharmacogenomic, biotechnical, nutritional or medical products or devices in terms of evaluating third party clinical research sites for their ability to provide contractual research trade services; arranging of contractual trade services with selected third parties to perform such trials and studies; arranging of contractual trade services with third parties to collect and test laboratory specimens from clinical trial and study sites; and advertising and business management consultancy regarding clinical trials and studies and the recruitment of patients and consumers for such trials and studiesACTIVE—
041Educational services in the nature of providing courses, training, testing and workshops in the field of clinical research, product lifecycle management, medical education, and distributing course materials in connection therewith; training clinical trial site and study site personnel in the use of tests and rating systems for protocol requirements; training clinical trial site personnel in the use of medical and research equipment required by trial and study protocols; and educational services in the nature of arranging for conference and seminar speakers through a speakers' bureauACTIVE—
042Product development and contract research services relating to public or private clinical trials or medical studies of pharmaceutical, pharmacies, nutritional, bio technical or medical products or devices; laboratory research testing in the fields of pharmacology, nutrition, biotechnology and medicine; conducting medical, scientific and data analysis research services for clinical trials or studies; development of clinical trial methodologies, protocol and project design, data retrieval methods, clinical data management and preparing statistical reports resulting from such clinical trials or studies; advisory services in the field of product development and research provided to physicians involved in the planning and preparation of lifecycle management activities for pharmaceutical, pharmacies, bio technical, nutritional, or medical products or devices; and technical consulting services in the nature of preparing and filing documents to comply with United States Food and Drug Administration requirements concerning clinical trialsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 3, 2010ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Mar 13, 2007MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 13, 2007ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 27, 2006EX1GSOU EXTENSION 1 GRANTED—
Jun 27, 2006EXT1SOU EXTENSION 1 FILED—
Jun 27, 2006EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 27, 2005NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 4, 2005PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 14, 2005NPUBNOTICE OF PUBLICATION—
Jun 21, 2005PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 15, 2005XAECEXAMINER'S AMENDMENT ENTERED—
Jun 10, 2005ALIEASSIGNED TO LIE—
Jun 3, 2005CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 3, 2005XAECEXAMINER'S AMENDMENT ENTERED—
Jun 1, 2005GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 1, 2005CNEAEXAMINERS AMENDMENT -WRITTEN—
May 6, 2005ACECAMENDMENT FROM APPLICANT ENTERED—
Apr 14, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 14, 2005MAILPAPER RECEIVED—
Oct 27, 2004XAECEXAMINER'S AMENDMENT ENTERED—
Oct 12, 2004GNPEEXAMINER'S AMENDMENT AND/OR PRIORITY ACTION E-MAILED—
Oct 12, 2004CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED—
Sep 28, 2004DOCKASSIGNED TO EXAMINER—
Apr 1, 2004NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance